Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

R-115777 radiosensitizes previously radioresistant human glioma cells

Aug. 22, 2002

In vitro and in vivo characterization of new KDR inhibitors disclosed by Merck

Aug. 21, 2002

Merck reports novel KDR inhibitors at ACS meeting

Aug. 21, 2002

Results on FTase inhibitor SCH-400 presented at ACS

Aug. 21, 2002

OSI and Genentech update progress of Tarceva development program

Aug. 21, 2002

Antioxidant epicatechin derivatives for use in cancer, cardiovascular disorders, etc.

Aug. 21, 2002

Abbott reports novel HDAC inhibitors at the ACS meeting

Aug. 20, 2002

Ras-MAPK signaling cascade inhibitors prepared and tested at Wyeth

Aug. 20, 2002

Potent, selective and orally bioavailable FTase inhibitor presented by Abbott

Aug. 20, 2002

Iressa NSCLC trial results show no improvement in combined treatment with standard chemotherapy

Aug. 20, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...